GAMCO INVESTORS, INC. ET AL - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
GAMCO INVESTORS, INC. ET AL ownership history of NOVARTIS A G
ValueSharesWeighting
Q4 2021$235,000
-79.5%
2,684
-79.5%
0.00%
-84.6%
Q2 2020$1,144,000
+5.9%
13,0950.0%0.01%0.0%
Q1 2020$1,080,000
-5.7%
13,095
+8.3%
0.01%
+44.4%
Q4 2019$1,145,000
+5.4%
12,095
-3.2%
0.01%0.0%
Q3 2019$1,086,000
-9.6%
12,495
-5.0%
0.01%0.0%
Q2 2019$1,201,000
+301.7%
13,155
+323.7%
0.01%
+350.0%
Q1 2019$299,000
+34.7%
3,105
+13.1%
0.00%
+100.0%
Q1 2018$222,000
-3.5%
2,7450.0%0.00%0.0%
Q4 2017$230,000
-50.3%
2,745
-49.1%
0.00%
-66.7%
Q3 2017$463,000
+0.9%
5,395
-1.8%
0.00%0.0%
Q2 2017$459,000
+10.1%
5,495
-2.2%
0.00%0.0%
Q1 2017$417,000
-2.6%
5,620
-4.3%
0.00%0.0%
Q4 2016$428,000
-13.5%
5,870
-6.3%
0.00%0.0%
Q3 2016$495,000
-0.2%
6,265
+4.2%
0.00%0.0%
Q2 2016$496,000
-0.2%
6,015
-12.4%
0.00%0.0%
Q1 2016$497,000
-21.9%
6,865
-7.1%
0.00%
-25.0%
Q4 2015$636,000
-8.2%
7,390
-2.0%
0.00%
-20.0%
Q3 2015$693,000
-15.4%
7,540
-9.5%
0.01%
+25.0%
Q2 2015$819,000
-15.6%
8,330
-15.3%
0.00%
-20.0%
Q1 2015$970,000
+9.1%
9,840
+2.6%
0.01%0.0%
Q4 2014$889,000
-7.3%
9,590
-5.9%
0.01%0.0%
Q3 2014$959,000
+3.5%
10,190
-0.5%
0.01%0.0%
Q2 2014$927,000
+1.5%
10,240
-4.7%
0.01%0.0%
Q1 2014$913,000
+4.8%
10,740
-0.9%
0.01%0.0%
Q4 2013$871,000
+4.7%
10,8400.0%0.01%0.0%
Q3 2013$832,000
+8.6%
10,8400.0%0.01%0.0%
Q2 2013$766,00010,8400.01%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders